Evidence map›Paper›PMID 37154033›Full record

ArticleCirculation research2023

Downregulation of FKBP5 Promotes Atrial Arrhythmogenesis.

Xiaolei Wang, Jia Song, Yue Yuan, Luge Li, Issam Abu-Taha, Jordi Heijman, Liang Sun, Shokoufeh Dobrev, Markus Kamler, Liang Xie and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. mScience China. Life sciences · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Xiaolei Wang *Department of Medicine (Section of Cardiovascular Research) (X.W., J.S., Y.Y., L.L., L.X., N.L.), Baylor College of Medicine, Houston, TX.ORCID 0009-0007-6808-5206
Jia Song *Department of Medicine (Section of Cardiovascular Research) (X.W., J.S., Y.Y., L.L., L.X., N.L.), Baylor College of Medicine, Houston, TX.ORCID 0000-0002-0815-208X
Yue Yuan *Department of Medicine (Section of Cardiovascular Research) (X.W., J.S., Y.Y., L.L., L.X., N.L.), Baylor College of Medicine, Houston, TX.
Luge LiDepartment of Medicine (Section of Cardiovascular Research) (X.W., J.S., Y.Y., L.L., L.X., N.L.), Baylor College of Medicine, Houston, TX.ORCID 0000-0002-4145-2607
Issam Abu-TahaInstitute of Pharmacology (I.A.-T., J.H., S.D., D.D.), West German Heart and Vascular Center, University of Duisburg-Essen, Germany.ORCID 0000-0002-2298-8959
Jordi HeijmanInstitute of Pharmacology (I.A.-T., J.H., S.D., D.D.), West German Heart and Vascular Center, University of Duisburg-Essen, Germany.ORCID 0000-0002-1418-108X
Liang SunDepartment of Integrative Physiology (L.S., X.H.T.W., F.T.H., D.D.), Baylor College of Medicine, Houston, TX.
Shokoufeh DobrevInstitute of Pharmacology (I.A.-T., J.H., S.D., D.D.), West German Heart and Vascular Center, University of Duisburg-Essen, Germany.
Markus KamlerDepartment of Thoracic and Cardiovascular Surgery (M.K.), West German Heart and Vascular Center, University of Duisburg-Essen, Germany.ORCID 0000-0001-6608-8496
Liang XieDepartment of Medicine (Section of Cardiovascular Research) (X.W., J.S., Y.Y., L.L., L.X., N.L.), Baylor College of Medicine, Houston, TX.
Xander H T WehrensDepartment of Integrative Physiology (L.S., X.H.T.W., F.T.H., D.D.), Baylor College of Medicine, Houston, TX.
Frank T HorriganDepartment of Integrative Physiology (L.S., X.H.T.W., F.T.H., D.D.), Baylor College of Medicine, Houston, TX.ORCID 0000-0001-6703-9581
Dobromir DobrevInstitute of Pharmacology (I.A.-T., J.H., S.D., D.D.), West German Heart and Vascular Center, University of Duisburg-Essen, Germany.ORCID 0000-0002-4612-117X
Na LiDepartment of Medicine (Section of Cardiovascular Research) (X.W., J.S., Y.Y., L.L., L.X., N.L.), Baylor College of Medicine, Houston, TX.ORCID 0000-0003-1307-3375
Baylor College of Medicine · USWest German Heart and Vascular Center Essen · DEMaastricht University · NLMontreal Heart Institute · CATwitter (United States) · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
UM1HG006348: Cas9 Genome Integrity Supplemental ProposalUM1HG006348 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI Jason D. Heaney, Chih-Wei Logan Hsu · 2016 to 2026
$47.5M
Ryanodine receptor regulation in post-operative atrial fibrillationR01HL089598 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI WEHRENS, XANDER H.T. · 2007 to 2022
$6.5M
The Role of Inflammasome in the Pathogenesis of Atrial FibrillationR01HL136389 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2017 to 2026
$5.6M
Sex-specific arrhythmogenic mechanisms of atrial fibrillationR01HL131517 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Eleonora Grandi · 2016 to 2026
$5.0M
METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITYR01DK114356 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2017 to 2025
$4.6M
Cardiac fibroblast inflammasome and atrial myopathyR01HL163277 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LI, NA · 2022 to 2025
$2.8M
Role of Nucleoside-Diphosphate Kinase Signaling in Atrial FibrillationR01HL160992 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Xander H.T. Wehrens · 2023 to 2026
$2.1M
Mechanisms underlying atrial fibrillation associated with chronic kidney diseaseR01HL147108 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LI, NA, WEHRENS, XANDER H.T. · 2019 to 2022
$2.0M
Explore the roles of intercellular communication in cardiomyocyte proliferation and renewal.R01HL166549 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Liang Xie · 2023 to 2026
$1.9M
FKBP5 AND CARDIAC ARRHYTHMOGENESISR01HL164838 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2024 to 2026
$1.7M
Vevo 3100 Ultrasound SystemS10OD032380 · OD · BAYLOR COLLEGE OF MEDICINE · PI WARD, CHRISTOPHER S · 2022 to 2022
$312k
NCI NIH HHS P30 CA125123NHGRI NIH HHS UM1 HG006348NHLBI NIH HHS R01 HL089598NHLBI NIH HHS R01 HL131517NHLBI NIH HHS R01 HL136389NHLBI NIH HHS R01 HL147108NHLBI NIH HHS R01 HL160992NHLBI NIH HHS R01 HL163277NHLBI NIH HHS R01 HL164838NHLBI NIH HHS R01 HL166549NIDDK NIH HHS R01 DK114356NIH HHS S10 OD032380
6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF), the most common arrhythmia, is associated with the downregulation of

methodsRight atrial samples from patients with AF were used to assess the protein levels of FKBP5. A cardiomyocyte-specific FKBP5 knockdown mouse model was established by crossbreeding

resultsFKBP5 protein levels were lower in the atrial lysates of patients with paroxysmal AF or long-lasting persistent (chronic) AF. Cardiomyocyte-specific knockdown mice exhibited increased AF inducibility and duration compared with control mice. Enhanced AF susceptibility in cardiomyocyte-specific knockdown mice was associated with the development of action potential alternans and spontaneous Ca

conclusionsThis is the first study to demonstrate a role for the FKBP5-deficiency in atrial arrhythmogenesis and to establish FKBP5 as a negative regulator of hypoxia-inducible factor 1α in cardiomyocytes. Our results identify a potential molecular mechanism for the proarrhythmic NCX1 upregulation in chronic AF patients.

Indexed as

Atrial FibrillationAnimalsDown-RegulationHeat-Shock ProteinsHypoxiaMiceMyocytes, CardiacTacrolimus Binding Protein 5Heat-Shock ProteinsTacrolimus Binding Protein 5animalsatrial fibrillationelectrophysiologymice

Identifiers

PMID37154033
PMCPMC10330339
OpenAlexW4375862671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.